Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma, Newly Diagnosed”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01239368
What this trial is testing

Th1/Tc1 Immunotherapy Following Stem Cell Transplantation in Multiple Myeloma

Who this might be right for
Myeloma, Plasma-CellMyeloma-MultipleMyelomatosis
National Cancer Institute (NCI) 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT04052880
What this trial is testing

Study of SubQ Dara With Dose-Attenuated Bortezomib, Lenalidomide, Dexamethasone in Elderly NDMM

Who this might be right for
Newly Diagnosed Multiple Myeloma
Larysa Sanchez 17
Testing effectiveness (Phase 2)Study completedNCT00925821
What this trial is testing

Lenalidomide-Adriamycin-Dexamethasone (RAD) Induction Followed by Stem Cell Transplant in Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Wuerzburg University Hospital 146
Post-approval studies (Phase 4)WithdrawnNCT04348006
What this trial is testing

Assessment of Bortezomib (Alvocade ®) Efficacy and Safety in Newly Diagnosed Multiple Myeloma Patients

Who this might be right for
Newly Diagnosed Multiple Myeloma
Al-Rasheed University College
Testing effectiveness (Phase 2)Study completedNCT01481194
What this trial is testing

ACVDL Treatment for Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Vejle Hospital 35
Testing effectiveness (Phase 2)Ended earlyNCT00843310
What this trial is testing

Combination of Revlimid, Melphalan and Dexamethasone as First Line Treatment for Multiple Myeloma

Who this might be right for
Multiple Myeloma
NYU Langone Health 8
Testing effectiveness (Phase 2)Looking for participantsNCT05573802
What this trial is testing

Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, Dexamethasone and Nirogacestat in Patients With Transplant Ineligible Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple MyelomaNeoplasmsNeoplasm, Plasma Cell+5 more
Hellenic Society of Hematology 36
Testing effectiveness (Phase 2)Study completedNCT02969837
What this trial is testing

Study of Initial Treatment With Elotuzumab, Carfilzomib, Lenalidomide and Dexamethasone in Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Chicago 46
Not applicableUnknownNCT05218603
What this trial is testing

Evaluation of Maintenance With Bortezomib Plus Daratumumab (V-Dara) After Induction With Bortezomib, Melphalan, Prednisone Plus Daratumumab (VMP-Dara) in Newly Diagnosed Multiple Myeloma (MM) Patients Non-eligible for autoSCT

Who this might be right for
Multiple MyelomaNon-eligible for Autologous Stem Cell Transplantation (ASCT)
PETHEMA Foundation 100
Not applicableStudy completedNCT02918695
What this trial is testing

Comparison of Geriatric Screening Methods in Newly Diagnosed Multiple Myeloma Patients

Who this might be right for
Multiple MyelomaHematologic Diseases
Universitaire Ziekenhuizen KU Leuven 200
Large-scale testing (Phase 3)Not Yet RecruitingNCT07732712
What this trial is testing

Isa-VRdlite for of Frail and/or Much Older Patients With High Risk Newly Diagnosed Multiple Myeloma Base on Circulating Plasma Cells

Who this might be right for
Multiple Myeloma
The Affiliated People's Hospital of Ningbo University 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT04113018
What this trial is testing

Study of Daratumumab Combined With Carfilzomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Wake Forest University Health Sciences 39
Testing effectiveness (Phase 2)Study completedNCT03417284
What this trial is testing

Melphalan Hydrochloride in Treating Participants With Newly-Diagnosed Multiple Myeloma Undergoing Donor Stem Cell Transplantation

Who this might be right for
Plasma Cell Myeloma
M.D. Anderson Cancer Center 62
Testing effectiveness (Phase 2)Study completedNCT02471820
What this trial is testing

Lenalidomide & Adriamycin & Dexamethasone (RAD) in Newly Diagnosed, Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Meletios A. Dimopoulos 45
Large-scale testing (Phase 3)Looking for participantsNCT07649525
What this trial is testing

Personalising Treatment for Myeloma Patients Based on Initial Response to NHS Treatment and Their Overall Fitness Level

Who this might be right for
Multiple Myeloma (MM)Plasma Cell Leukemia (PCL)
University of Leeds 1,226
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07828522
What this trial is testing

F182112 in Combination With Isatuximab and Lenalidomide for the Treatment of Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma (MM)Transplant-eligible Patients
Institute of Hematology & Blood Diseases Hospital, China 10
Not applicableLooking for participantsNCT07226609
What this trial is testing

A Dietary Study for People With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 220
Testing effectiveness (Phase 2)Study completedNCT01668719
What this trial is testing

S1211 Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma

Who this might be right for
DS Stage I Plasma Cell MyelomaDS Stage II Plasma Cell MyelomaDS Stage III Plasma Cell Myeloma
SWOG Cancer Research Network 142
Testing effectiveness (Phase 2)Looking for participantsNCT05272826
What this trial is testing

Study of Iberdomide, Bortezomib, Dexamethasone With Isatuximab Added on Demand for ND-NTE MM Patients

Who this might be right for
Multiple Myeloma
Canadian Myeloma Research Group 75
Testing effectiveness (Phase 2)Ended earlyNCT01729338
What this trial is testing

Velcade + Cyclophosphamide in Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Duke University 17
Next Page